These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27737791)

  • 1. A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2017 Jan; 317():494-501. PubMed ID: 27737791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Pharmacol Biochem Behav; 2017 Feb; 153():160-167. PubMed ID: 28063946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Custodio RJ; Woo T; Seo JW; Jang CG; Yang JS; Yoon YM; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2018 Apr; 341():122-128. PubMed ID: 29288746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Abuse Potential of α-Piperidinopropiophenone (PIPP) and α-Piperidinopentiothiophenone (PIVT), Two New Synthetic Cathinones with Piperidine Ring Substituent.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Biomol Ther (Seoul); 2017 Mar; 25(2):122-129. PubMed ID: 28173643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
    Oh JH; Hwang JY; Hong SI; Ma SX; Seo JY; Lee SY; Kim HC; Jang CG
    Addict Biol; 2018 Jan; 23(1):69-79. PubMed ID: 27790823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral evidence for the abuse potential of the novel synthetic cathinone alpha-pyrrolidinopentiothiophenone (PVT) in rodents.
    Cheong JH; Choi MJ; Jang CG; Lee YS; Lee S; Kim HJ; Seo JW; Yoon SS
    Psychopharmacology (Berl); 2017 Mar; 234(5):857-867. PubMed ID: 28070621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.
    Oliver CF; Simmons SJ; Nayak SU; Smith GR; Reitz AB; Rawls SM
    Drug Alcohol Depend; 2018 May; 186():75-79. PubMed ID: 29550625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C; Anderson KL; Itzhak Y
    Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.
    Gregg RA; Hicks C; Nayak SU; Tallarida CS; Nucero P; Smith GR; Reitz AB; Rawls SM
    Neuropharmacology; 2016 Sep; 108():111-9. PubMed ID: 27085607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential rewarding and reinforcing effects of the substituted benzofurans 2-EAPB and 5-EAPB in rodents.
    Sayson LV; Custodio RJP; Ortiz DM; Lee HJ; Kim M; Jeong Y; Lee YS; Kim HJ; Cheong JH
    Eur J Pharmacol; 2020 Oct; 885():173527. PubMed ID: 32871174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives.
    Gatch MB; Dolan SB; Forster MJ
    J Pharmacol Exp Ther; 2015 Aug; 354(2):103-10. PubMed ID: 25998047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.
    Simmons SJ; Leyrer-Jackson JM; Oliver CF; Hicks C; Muschamp JW; Rawls SM; Olive MF
    ACS Chem Neurosci; 2018 Oct; 9(10):2379-2394. PubMed ID: 29714473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat.
    Steiner MA; Lecourt H; Jenck F
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):417-32. PubMed ID: 22436395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: relationship with serotonin and dopamine in the striatum.
    Haleem DJ; Ikram H; Haleem MA
    Brain Res; 2014 Oct; 1586():73-82. PubMed ID: 25160128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of learned behavior upon conditioned place preference to cathinone.
    Schechter MD
    Pharmacol Biochem Behav; 1991 Jan; 38(1):7-11. PubMed ID: 1673251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones.
    Duart-Castells L; Nadal-Gratacós N; Muralter M; Puster B; Berzosa X; Estrada-Tejedor R; Niello M; Bhat S; Pubill D; Camarasa J; Sitte HH; Escubedo E; López-Arnau R
    Neuropharmacology; 2021 Mar; 186():108475. PubMed ID: 33529677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.
    Philogene-Khalid HL; Hicks C; Reitz AB; Liu-Chen LY; Rawls SM
    Drug Alcohol Depend; 2017 Sep; 178():119-125. PubMed ID: 28646714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels.
    Abiero A; Botanas CJ; Custodio RJ; Sayson LV; Kim M; Lee HJ; Kim HJ; Lee KW; Jeong Y; Seo JW; Ryu IS; Lee YS; Cheong JH
    Psychopharmacology (Berl); 2020 Mar; 237(3):757-772. PubMed ID: 31828394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopaminergic alterations induced by 4-F-PCP and 4-Keto-PCP may enhance their drug-induced rewarding and reinforcing effects: Implications for abuse.
    Ortiz DM; Custodio RJP; Abiero A; Botanas CJ; Sayson LV; Kim M; Lee HJ; Kim HJ; Jeong Y; Yoon S; Lee YS; Cheong JH
    Addict Biol; 2021 Jul; 26(4):e12981. PubMed ID: 33135332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.
    Riddle JL; Rokosik SL; Napier TC
    Behav Brain Res; 2012 Jul; 233(1):15-23. PubMed ID: 22727039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.